z-logo
open-access-imgOpen Access
Hematologic Malignant Neoplasms After Drug Exposure in Rheumatoid Arthritis
Author(s) -
Sasha Bernatsky
Publication year - 2008
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2007.107
Subject(s) - medicine , rheumatoid arthritis , cyclophosphamide , population , azathioprine , concomitant , methotrexate , surgery , disease , chemotherapy , environmental health
Rheumatoid arthritis is a severe inflammatory polyarthritis that requires long-term treatment with disease-modifying antirheumatic drugs. There is increasing concern about the influence of rheumatoid arthritis therapy on the risk for hematologic malignant neoplasms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom